Reports on Atherosclerosis Findings from University of South China Provide New Insights (High-density Lipoprotein Subfractions Remodeling: a Critical Process for the Treatment of Atherosclerotic Cardiovascular Diseases).

A study conducted at the University of South China in Hengyang, People's Republic of China, explores the role of high-density lipoprotein (HDL) in the treatment of atherosclerotic cardiovascular diseases. While raising HDL cholesterol levels is often seen as a promising strategy, the research suggests that the effectiveness of HDL-raising therapy in preventing and treating ASCVD is uncertain due to the heterogeneity of HDL particles. The study reviews how lipid-modifying drugs regulate the cholesterol concentration of specific HDL subfractions, providing new insights into potential treatment approaches. [Extracted from the article]

Copyright of Cardiovascular Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)